As of April 2024 Takeda Pharmaceutical has a market cap of $41.56 Billion. This makes Takeda Pharmaceutical the world's 446th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $41.56 B | -7.75% |
2023 | $45.05 B | -7.11% |
2022 | $48.50 B | 13.56% |
2021 | $42.71 B | -24.96% |
2020 | $56.92 B | -8.14% |
2019 | $61.96 B | 136.23% |
2018 | $26.23 B | -40.77% |
2017 | $44.29 B | 35.96% |
2016 | $32.57 B | -17.68% |
2015 | $39.57 B | 19.85% |
2014 | $33.02 B | -9.04% |
2013 | $36.30 B | 2.57% |
2012 | $35.39 B | 1.67% |
2011 | $34.81 B | -9.45% |
2010 | $38.44 B | 18.49% |
2009 | $32.44 B | -29.16% |
2008 | $45.79 B |
On Apr 18th, 2024 the market cap of Takeda Pharmaceutical was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $351.20 B | 744.97% | ๐บ๐ธ USA |
Novartis NVS | $189.69 B | 356.39% | ๐จ๐ญ Switzerland |
Pfizer PFE | $143.77 B | 245.91% | ๐บ๐ธ USA |
Amgen AMGN | $140.93 B | 239.08% | ๐บ๐ธ USA |
Sanofi SNY | $114.19 B | 174.76% | ๐ซ๐ท France |
Merck MRK | $317.21 B | 663.19% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $80.75 B | 94.29% | ๐ฌ๐ง UK |
Seagen
SGEN | $43.15 B | 3.83% | ๐บ๐ธ USA |
Dr. Reddy's RDY | $11.87 B | -71.44% | ๐ฎ๐ณ India |